Pipeline
powered by ExceBM™ Technique Platform
Main Pipelines |
Product |
Indications |
Process |
|---|---|---|---|
|
General Surgery |
ExceReg™ Biological Surgical Graft |
The only laparoscopic hernia mesh in China. |
Approved by NMPA |
|
Gynecology |
ExcePelv™ Pelvic Graft |
The Only Bioproduct for the indication in China. |
Estimated by 2024 |
|
General Surgery |
ExceReg™ Plus Biological Surgical Graft |
Only Product for Abdominal cavity separation in China. |
Estimated by 2024 |
|
General Surgery |
ExceReg™ Plus Antibacterial Surgical Graft |
The Only product for the indication. |
Estimated by 2025 |
|
Neurosurgery |
ExceMend™ Dural (Spinal) Graft |
Degradable, anti-adhension membrane |
Approved by NMPA |
|
Dental |
ExceOra™ Oral Membrane |
The only Chinese company owns membrane and nail product. |
Estimated by 2024 |
|
Wound Dressing |
ExceFil™ Wound Membrane |
Only product focus on severe wound healing |
Estimated by 2024 |
|
Wound Dressing |
ExceFil™ Wound Particulate |
The Only product for the indication in China. |
Estimated by 2024 |